A double-J catheter is a thin, flexible tube placed inside the ureter, the narrow duct that carries urine from the kidney to the bladder, to keep it open when something is blocking or threatening to block the flow. The name comes from the tube’s shape: each end curls into a “J”-shaped coil, one anchored in the kidney and the other in the bladder, so the stent stays in place without external fixation. These devices are among the most commonly used tools in urology, placed in both emergency and planned settings to relieve obstruction and protect healing tissue after surgery.
Why a Double-J Catheter Gets Placed
The single most common reason is a ureteral stone that is blocking urine drainage. When a kidney stone lodges in the ureter and causes severe pain, infection, or a dangerous backup of urine into the kidney, a double-J stent can be slid past or alongside the stone to restore flow immediately. Beyond stones, the stent has a long list of uses. It may be placed before or after stone-removal procedures such as ureteroscopy, percutaneous kidney surgery, or shockwave lithotripsy to keep the ureter from swelling shut during healing.1PubMed. Frequency and indications for double-J stenting in endourology: a review by the EAU section of endourology Chronic obstruction from scar tissue, a tumor pressing on the ureter from outside, or reconstructive urological surgery are also routine indications. In emergency situations where the urinary tract needs decompression fast, the stent remains a first-line option.
How the Design Works
The curled ends are the defining feature. Early ureteral stents were straight tubes that tended to slide out of position, migrate into the kidney, or fall into the bladder. In the 1970s, a stent with coiled “pigtail” ends was developed, and that innovation largely solved the migration problem.2Journal of Clinical Urology. Ureteric stents: The past, present and future The upper coil sits in the renal pelvis (the collecting area inside the kidney), and the lower coil rests in the bladder. The coils exert a gentle spring-like force against the walls, holding the stent in position without stitches or clips. Research on how the number of coil turns affects retention force has found that stents with more coil turns grip more firmly, though the effect also depends on the stent’s material and overall geometry.3PubMed. Influence of coil number on the retention strength of ureteral stents: an experimental investigation
Urine drainage through a stented ureter happens by two routes simultaneously. Some urine flows through the hollow center of the tube, entering and exiting through side holes along its length. The rest flows around the outside of the stent, in the narrow space between the tube and the ureteral wall. Which route carries more urine depends on factors like kidney pressure, bladder pressure, the degree of obstruction, and the diameter of the stent itself.4PLOS ONE. Investigating the Flow Dynamics in the Obstructed and Stented Ureter by Means of a Biomimetic Artificial Model This dual-path drainage is one reason the stent works even when its lumen partially clogs with debris or mineral deposits.
What Having a Stent Actually Feels Like
If you have just been told you need a double-J stent, the question you probably care about most is comfort. The honest answer: most people feel the stent, and many find it significantly bothersome. The lower coil sits inside the bladder, where it rubs against the sensitive lining, especially the trigone (the area near the bladder outlet). That mechanical irritation triggers frequent urges to urinate, a burning sensation during urination, and sometimes a sense of incomplete emptying. The stent can also allow small amounts of urine to reflux backward from the bladder toward the kidney, causing flank discomfort that worsens with physical activity or a full bladder.
A study of 200 patients who received double-J stents after kidney-stone surgery found that about 83% experienced pain, and more than three-quarters reported interrupted sleep. Urgency was nearly universal, affecting over 90% of patients, and half reported painful urination. Visible blood in the urine occurred in 40% of cases. All of these symptoms improved markedly once the stent was removed.5International Journal of Clinical Urology. Symptoms and Impact of Double-J Stent on the Quality of Life After Percutaneous Nephrolithotomy in Vietnam In a separate analysis looking at what drove the biggest drops in quality of life, pain stood out as the strongest factor, followed by difficulties with sexual activity and the ability to work normally.6PubMed Central. Impact of Double-J Stent on Patient Outcomes and Healthcare Costs in Saudi Arabia: A Retrospective Cross-Sectional Study From a Tertiary Care Center The impact goes beyond physical discomfort into daily functioning, which is worth knowing before placement so you can plan time off work and adjust expectations.
Medications That Help With Stent Symptoms
The discomfort is real, but there are pharmacological tools that take the edge off. Alpha-blockers, the same class of drugs sometimes used for enlarged prostate, relax smooth muscle in the ureter and bladder neck. Tamsulosin is the most widely studied option. A randomized trial found that patients taking tamsulosin had significantly lower irritative and obstructive urinary symptom scores at both two and four weeks compared to those on placebo, along with better pain and physical-function scores on a general quality-of-life survey.7PubMed. Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: a randomized controlled study
For patients who remain symptomatic despite standard doses, combining tamsulosin with an anticholinergic drug like solifenacin (which calms bladder spasms) can offer additional relief. Research comparing standard-dose and doubled-dose combinations found that the higher dose produced significantly greater symptom reduction, though with a trade-off of more frequent but manageable side effects such as dry mouth and constipation.8PubMed Central. Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms If you are struggling with stent symptoms and have not been offered any medication, it is reasonable to ask your urologist about these options.
Biofilm and Infection
Any foreign object sitting in the urinary tract becomes a target for bacteria. Within days of placement, a thin protein film coats the stent surface, and bacteria can latch onto it and form organized colonies called biofilms. These biofilms are notoriously difficult for the immune system and antibiotics to penetrate. In a prospective study of 48 stents, bacteria were detected on more than half of the removed devices, with Enterococcus species, Pseudomonas, and E. coli being the most common colonizers. The longer the stent stayed in, the higher the colonization rate.9PubMed Central. Risk factors for bacterial stent colonization in patients with a double J ureteral stent: a prospective study
What makes this clinically tricky is that the bacterial populations on the stent can differ from those in the surrounding urine. One analysis found that the stent surface harbored bacteria at a substantially higher rate than urine samples from the same patients. The dominant organism on the stent was Enterococcus faecalis, while E. coli dominated the urine cultures. More concerning, bacteria living on the stent surface showed higher antibiotic resistance rates than those floating in urine, including resistance to powerful drugs typically reserved for serious infections.10Infection and Drug Resistance. Analysis of Characteristics, Pathogens and Drug Resistance of Urinary Tract Infection Associated with Long-Term Indwelling Double-J Stent This is one of the strongest arguments for not leaving a stent in any longer than necessary.
Encrustation and Mineral Buildup
Closely related to biofilm is encrustation, the gradual coating of the stent with mineral crystite deposits. The process is driven by multiple overlapping factors: how long the stent stays in, the patient’s urine chemistry, the formation of the initial protein film, bacterial colonization, and the eventual deposition of urinary minerals on top of all that.11PubMed. Ureteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology The crystalline deposits are mostly calcium oxalate and calcium phosphate, with struvite (a magnesium-containing mineral) sometimes appearing, particularly when a urinary tract infection is present.12Urologia Internationalis. Double-J Ureteric Stent Encrustations: Clinical Study on Crystal Formation on Polyurethane Stents Surface irregularities on the stent and existing biofilms act as starting points for crystal growth, accelerating the process.13PubMed Central. Calcified double-J stent: Case report and review of recent literature
Mild encrustation may cause no problems and is simply noted when the stent is pulled. Severe encrustation, on the other hand, can turn stent removal into a multi-step surgical challenge. A review spanning 50,000 stent procedures documented over 800 cases of significant encrustation and calcification, plus 52 cases of stent fragmentation where the stent actually broke during or before attempted removal.14PubMed Central. Ureteral stent complications – experience on 50,000 procedures Heavily encrusted or broken stents typically require a combination of endoscopic techniques, such as ureteroscopy with laser to fragment the mineral coating before the stent can be safely extracted.15PubMed Central. Broken double-J stent in a 40-year-old male with a history of ureteral calculus
The Forgotten Stent Problem
One of the more preventable complications is simply forgetting the stent is there. Unlike a cast on a broken arm, which is visible and impossible to ignore, a double-J catheter is completely internal and produces symptoms that many patients eventually adapt to. If the follow-up appointment to remove it falls through the cracks, the stent can remain in place for months or even years, far beyond its intended dwell time. Forgotten stents are associated with heavy encrustation, recurrent infections, and kidney damage, along with legal disputes between patients and providers.16PubMed. Development and Validation of the Stent Tracking Algorithm Registry for Monitoring and Retrieving Forgotten Ureteral Stents
This is a recognized enough hazard that hospitals have developed electronic tracking systems and smartphone apps specifically to prevent it. One approach uses automated alerts built into the hospital’s electronic medical records to flag patients who are overdue for stent removal. Another team tested a smartphone-based stent-tracking application and compared it to old-fashioned appointment cards, finding that the digital approach was more effective at ensuring patients returned on time.17PubMed Central. Smartphone-based stent tracking application for prevention of forgotten ureteral double-J stents: a prospective study If you have a stent, make sure you have a firm removal date in your calendar and a plan if something comes up. This is one area where being a proactive patient genuinely matters.
How the Stent Gets Removed
Standard removal is done with a cystoscope, a thin camera that passes through the urethra into the bladder. The urologist grabs the lower coil of the stent with a small grasper and gently pulls it out. The procedure takes a few minutes and is usually done in an office setting with local anesthetic gel, though most patients describe it as uncomfortable rather than painful. Occasionally, resistance during removal signals that the stent has become knotted, a rare but well-documented complication. Gentle traction works in roughly a third of knotted-stent cases, but if resistance is strong, forcing it risks ureteral injury, and alternative techniques like ureteroscopy or even open surgery may be needed.18PubMed Central. Knotted double j ureteral stent: a case report and literature review
An emerging alternative uses stents with a small magnet embedded in the bladder coil. Instead of a cystoscope, the magnet allows the stent to be grabbed and pulled out using a catheter-like retrieval device threaded into the bladder. A systematic review found that magnetic stent removal consistently caused less pain than cystoscopic removal, with no trade-off in terms of stent performance while in place.19Irish Journal of Medical Science (1971 -). A systematic review of magnetic versus conventional ureteric stents for short term ureteric stenting A direct comparison between the two approaches also showed a cost saving of roughly €200 per patient with the magnetic system, primarily because the removal does not require a cystoscopy suite or the associated staff time.20PubMed. Ureteric stenting with magnetic retrieval: an alternative to traditional methods
Newer Materials and Coatings
Much of the current innovation in stent design focuses on making the experience less miserable and reducing complications. Hydrophilic coatings, which make the stent surface slippery when wet, are one of the more promising advances. A randomized trial comparing hydrophilic-coated polyurethane stents to uncoated ones found that patients with coated stents had significantly lower urinary symptom scores, substantially less pain, and better overall quality of life. Strikingly, 60% of patients with the coated stent reported no pain at all, compared to fewer than 8% in the uncoated group.21PubMed Central. A randomized controlled trial comparing hydrophilic coated to uncoated polyurethane double J stents: Does it impact stent-related symptoms? Diamond-like carbon coatings are another commercially available option, designed to resist bacterial adhesion and mineral deposition.22Urinary Stents. Coatings for Urinary Stents: Current State and Future Directions
Beyond coatings, researchers are working on stents that dissolve on their own, eliminating the need for a removal procedure entirely. A biodegradable stent called Uriprene was tested in an animal model and began breaking down at three weeks. By ten weeks, every stent had fully degraded. The stent provided drainage equivalent to conventional stents while causing less ureteral dilation and fewer urinary tract infections.23PubMed. Investigation of a novel degradable ureteral stent in a porcine model If self-dissolving stents eventually make it through human trials and into routine use, they could eliminate both the discomfort of a removal visit and the entire category of forgotten-stent complications.
Metallic Stents for Long-Term or Malignant Obstruction
Standard polymer stents work well for short-term use, but patients with chronic obstruction from cancer or scar tissue face a different challenge. These patients often need drainage for months to years, and polymer stents in this setting require frequent exchanges every few months to prevent encrustation and blockage. Metallic ureteral stents offer a longer-lasting alternative. Made from materials like nickel-titanium alloy, they resist encrustation better and can remain functional for longer stretches without replacement.
Metal stents have been used to relieve obstruction from both benign conditions like retroperitoneal fibrosis and malignant causes such as pelvic tumors compressing the ureters.24PubMed. Metal ureteral stent for benign and malignant ureteral obstruction Not all metallic designs perform equally. A comparison of two types found that one (the UVENTA stent) achieved a clinical success rate of about 82%, while the other (Memokath 051) succeeded in roughly 43% of cases, a significant gap that underscores how much design details matter even within the same broad category.25PubMed Central. Stents for malignant ureteral obstruction Metallic stents are not appropriate for everyone and carry their own risks, including tissue ingrowth into the stent mesh, but for patients facing repeated exchanges of polymer stents, they can meaningfully reduce the procedure burden.
Special Populations
Double-J stents are not limited to adults with kidney stones. They are used across a range of patients, including two groups that often prompt specific concern: pregnant women and children.
During pregnancy, the growing uterus can compress the ureters, and kidney stones occur at a rate that makes urologists a regular part of some obstetricians’ call lists. Treatment options are limited because radiation from imaging and many surgical tools pose risks to the fetus. Double-J stenting offers a way to relieve obstruction without major surgery. A single-center review of pregnant patients who underwent stenting found it to be safe and effective, with reassuring pregnancy outcomes.26PubMed Central. Pregnancy Outcomes in a Cohort of Patients Who Underwent Double-J Ureteric Stenting—A Single Center Experience The downside is that stents in pregnant patients often need to be exchanged every four to six weeks due to faster encrustation rates, making the final trimester a particularly tedious stretch of repeated procedures.
In children, the stent is used for conditions like primary obstructive megaureter, where a segment of the ureter fails to propel urine forward normally. One series found that placing a double-J stent endoscopically resolved the obstruction in about two-thirds of cases, and complications were uncommon.27PubMed Central. Endoscopic placement of double-J ureteric stents in children as a treatment for primary obstructive megaureter When the standard route through the bladder is not feasible, the stent can be placed through the skin and kidney using ultrasound guidance, an approach that has been shown to be safe and successful in small pediatric series.28PubMed. Percutaneous insertion of double-J ureteral stent in children with ureteral obstruction: our experiences Children cannot always articulate stent-related discomfort the way adults can, so monitoring for behavioral changes, frequent crying during urination, or new bedwetting is important during the dwell period.
The Cost Side of the Equation
Stent-related morbidity is not just a clinical issue; it carries real economic weight. The costs include not only the stent itself and the procedures to place and remove it, but also the downstream expenses from managing complications: emergency visits for pain, antibiotic courses for infections, imaging to check for migration, and additional procedures to deal with encrusted or broken stents. An economic analysis concluded that the financial burden of stent-related morbidity is considerable and should factor into the decision of whether to place a stent at all, particularly in cases where stenting is not strictly necessary.29PubMed. Economic Aspects of Morbidity Caused by Ureteral Stents This is an active conversation in urology: many post-ureteroscopy patients historically received a stent as routine practice, and there is growing evidence that in uncomplicated cases, some patients can safely go without one, sparing them the symptoms and the follow-up visit for removal.